Diagnostic Significance of Serum Galectin-3 in Hospitalized Patients with COVID-19—A Preliminary Study

Diagnostic Significance of Serum Galectin-3 in Hospitalized Patients with COVID-19—A Preliminary Study

Severe coronavirus disease 2019 (COVID-19) is associated with hyperinflammation leading to organ injury, including respiratory failure. Galectin-3 was implicated in innate immunological response to infections and in chronic fibrosis. The aim of our preliminary study was the assessment of the diagnos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beata Kuśnierz-Cabala, Barbara Maziarz, Paulina Dumnicka, Marcin Dembiński, Maria Kapusta, Monika Bociąga-Jasik, Marek Winiarski, Aleksander Garlicki, Tomasz Grodzicki, Michał Kukla
Formato:	Artículo
Lenguaje:	English
Publicado:	MDPI AG 2021-08-01
Colección:	Biomolecules
Materias:	galectin-3 soluble fms-like tyrosine kinase-1 SARS-CoV-2 COVID-19 inflammation
Acceso en línea:	https://www.mdpi.com/2218-273X/11/8/1136

Ejemplares similares

The Role of the Aryl Hydrocarbon Receptor in Vascular Factors Related to Preeclampsia in a Smoking Mouse Model
por: Ho-Yeon Kim, et al.
Publicado: (2024-01-01)

Prognostic value of serum soluble FMS-like tyrosine kinase (sFlt-1) levels in pre-eclampsia and eclampsia; a prospective cohort study
por: Ahmed M. Abbas, et al.
Publicado: (2018-07-01)

Distinct phenotypes in the preeclamptic-like mouse model induced by adenovirus carrying sFlt1 and recombinant sFlt1 protein
por: Yingying Wei, et al.
Publicado: (2024-12-01)

An Examination of the Effect of Aspirin and Salicylic Acid on Soluble Fms-like Tyrosine Kinase-1 Release from Human Placental Trophoblasts
por: Jiawu Zhao, et al.
Publicado: (2024-01-01)

Use of serum and urinary soluble sFlt-1 and PLGF in the diagnosis of preeclampsia
por: Ping Tang, et al.
Publicado: (2017-01-01)

Short-Term Prediction of Preeclampsia in Chinese Women Using the Soluble fms-Like Tyrosine Kinase 1/Placental Growth Factor Ratio: A Sub-Analysis of the PROGNOSIS Asia Study
por: Jinsong Gao, et al.
Publicado: (2021-08-01)

Soluble fms-like tyrosine kinase-1 and vascular endothelial growth factor: Novel markers for unexplained early recurrent pregnancy loss
por: Mahmoud Fathy Hassan
Publicado: (2014-03-01)

Nephrotic syndrome due to preeclampsia before 20 weeks of gestation: a case report
por: Tomo Suzuki, et al.
Publicado: (2020-06-01)

Relation between FMS-like tyrosine kinase 3 factor and hematological parameter in acute lymphoblastic leukemia patients by flow cytometry
por: Zainab Samir Al-Ali, et al.
Publicado: (2022-01-01)

Soluble fms-like tyrosine kinase 1 and placental growth factor ratio for predicting preeclampsia in elderly gravida
por: Vorapong Phupong, et al.
Publicado: (2020-04-01)

Placental growth fActor Repeat sampling for Reduction of adverse perinatal Outcomes in women with suspecTed pre-eclampsia: study protocol for a randomised controlled trial (PARROT-2)
por: Alice Hurrell, et al.
Publicado: (2022-09-01)

Circulating angiogenic factors and HIV among pregnant women in Zambia: a nested case–control study
por: Megan E. Smithmyer, et al.
Publicado: (2021-07-01)

Anti-inflammatory adipokines: chemerin, vaspin, omentin concentrations and SARS-CoV-2 outcomes
por: Michał Kukla, et al.
Publicado: (2021-11-01)

The role of proangiogenic cytokines in predicting sepsis in febrile neutropenic children with cancer
por: Selma Çakmakcı, et al.
Publicado: (2024-02-01)

Role of soluble fms-like tyrosine kinase-1/placental growth factor ratio along with uterine artery Doppler for the prediction of pre-eclampsia – A case–control study
por: Sathya Jagdish, et al.
Publicado: (2024-05-01)

Correlation of sFlt/PlGF ratio with severity of preeclampsia in an Indian populationAJOG Global Reports at a Glance
por: Namrata Kumar, MD, MRCOG, EFOG, FACOG, et al.
Publicado: (2023-05-01)

No association between early antiretroviral therapy during pregnancy and plasma levels of angiogenic factors: a cohort study
por: Ameyo Djeha, et al.
Publicado: (2019-12-01)

Targeting FLT3 Mutations in Acute Myeloid Leukemia
por: Riad El Fakih, et al.
Publicado: (2018-01-01)

Human umbilical cord mesenchymal stem cell derived exosomes (HUCMSC-exos) recovery soluble fms-like tyrosine kinase-1 (sFlt-1)-induced endothelial dysfunction in preeclampsia
por: Xinwen Chang, et al.
Publicado: (2023-08-01)

Angiogenic Biomarker Placental Growth Factor (PLGF) in the Prediction and Diagnosis of Placental Dysfunction in Pre-eclampsia: A Cohort Study
por: Mandeep Kaur, et al.
Publicado: (2023-06-01)

Soluble fms‐like tyrosine kinase‐1‐enriched exosomes suppress the growth of small cell lung cancer by inhibiting endothelial cell migration
por: Dexun Hao, et al.
Publicado: (2019-10-01)

Fetuin-A Deficiency but Not Pentraxin 3, FGF-21, or Irisin, Predisposes to More Serious COVID-19 Course
por: Michał Kukla, et al.
Publicado: (2021-09-01)

Effect of galectin‐1 on prognosis and responsiveness of immune checkpoint plus tyrosine kinase inhibition in renal cell carcinoma
por: Jiajun Wang, et al.
Publicado: (2024-04-01)

Comparative analysis of galectin-1, galectin-3, and galectin-8 signatures in normal and choriocarcinoma trophoblast cell lines
por: Jovanović Krivokuća Milica, et al.
Publicado: (2024-01-01)

Evaluation of Serum Soluble fms-like Tyrosine Kinase-1 as a Biomarker in Ectopic Pregnancy
por: Alaa Raeed, et al.
Publicado: (2024-04-01)

Diagnostic value of sFlt‐1/PlGF‐1 ratio and plasma PROK1 for adverse pregnancy outcomes in women with hypertensive disease of pregnancy
por: Ping Lv, et al.
Publicado: (2024-12-01)

A cross sectional study to assess the sFlt-1:PlGF ratio in pregnant women with and without preeclampsia
por: Vivek Pant, et al.
Publicado: (2019-07-01)

Galectin Family Members: Emerging Novel Targets for Lymphoma Therapy?
por: Yuanwei Shi, et al.
Publicado: (2022-05-01)

Is the sFlt-1/PlGF ratio efficient in predicting adverse neonatal outcomes in small-for-gestational-age newborns? A prospective observational multicenter cohort study
por: Katarzyna Kosińska-Kaczyńska, et al.
Publicado: (2024-06-01)

The Importance of Inflammatory and Angiogenic Markers in the Evaluation of Early Cardiovascular Disease Risk in Women with Hypertensive Disorders of Pregnancy
por: Tatjana Maselienė, et al.
Publicado: (2023-09-01)

THE ROLE OF THE PIGF/SFLT-1 RELATIONSHIP IN PREDICTING PREECLAMPSIA (LITERATURE REVIEW)
por: Irina Venzkovskaya, et al.
Publicado: (2019-04-01)

Serum placental growth factor and soluble fms-like tyrosine kinase-1 in preeclamptic women at their third trimester of pregnancy
por: Nesreen Nasser, et al.
Publicado: (2020-12-01)

Recent Advances in the Development of Anti-FLT3 CAR T-Cell Therapies for Treatment of AML
por: Maya Graham Pedersen, et al.
Publicado: (2022-09-01)

Evaluation of the CD123 Expression and FLT3 Gene Mutations in Patients with Acute Myeloid Leukemia
por: Freidoon Solhjoo, et al.
Publicado: (2018-10-01)

Galectins as Checkpoints of the Immune System in Cancers, Their Clinical Relevance, and Implication in Clinical Trials
por: Daniel Compagno, et al.
Publicado: (2020-05-01)

Galectin-3 not Galectin-9 as a candidate prognosis marker for hepatocellular carcinoma
por: Fei Kong, et al.
Publicado: (2020-09-01)

The role of salivary galectin-3 and galectin-9 levels in plaque-induced gingivitis and periodontitis
por: Zerrin Barut, et al.
Publicado: (2023-09-01)

Evaluation of Plasma Concentrations of Galectins-1, 2 and 12 in Psoriasis and Their Clinical Implications
por: Julia Nowowiejska, et al.
Publicado: (2023-09-01)

Added value of mean blood pressure and placental growth factor in the early detection of pre-eclampsia among gabonese women
por: Elisabeth Lendoye, et al.
Publicado: (2024-01-01)

Maternal serum soluble fms-like tyrosine kinase-1–to–placental growth factor ratio distinguishes growth-restricted from non–growth-restricted small-for-gestational-age fetusesAJOG Global Reports at a Glance
por: Prithi Rajiv, MD, et al.
Publicado: (2024-02-01)